31 related articles for article (PubMed ID: 27418270)
1. A comparison of analytic approaches for investigating the obesity paradox in kidney cancer.
Olsson LT; Eberle CE; Petruzella S; Robinson WR; Furberg H
Cancer Causes Control; 2023 Apr; 34(4):361-370. PubMed ID: 36786871
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.
Chamie K; Donin NM; Klöpfer P; Bevan P; Fall B; Wilhelm O; Störkel S; Said J; Gambla M; Hawkins RE; Jankilevich G; Kapoor A; Kopyltsov E; Staehler M; Taari K; Wainstein AJA; Pantuck AJ; Belldegrun AS
JAMA Oncol; 2017 Jul; 3(7):913-920. PubMed ID: 27787547
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.
Choi C; Kang M; Seo SI; Suh J; Song C; Chung J; Kim SH; Park JY; Hwang EC; Jeong CW; Kwak C; Kim JK; Hong SH
J Korean Med Sci; 2024 Jan; 39(3):e11. PubMed ID: 38258358
[TBL] [Abstract][Full Text] [Related]
4. Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma.
Bobulescu IA; Pop LM; Mani C; Turner K; Rivera C; Khatoon S; Kairamkonda S; Hannan R; Palle K
Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564424
[TBL] [Abstract][Full Text] [Related]
5. Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.
Purdue MP; Rhee J; Moore L; Gao X; Sun X; Kirk E; Bencko V; Janout V; Mates D; Zaridze D; Petruzella S; Hakimi AA; Linehan WM; Chanock SJ; Brennan P; Furberg H; Troester M; Rothman N
Int J Cancer; 2021 Oct; 149(7):1448-1454. PubMed ID: 34058014
[TBL] [Abstract][Full Text] [Related]
6. Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~.
Tsutsumi T; Komura K; Hashimoto T; Muraoka R; Satake N; Matsunaga T; Tsujino T; Yoshikawa Y; Takai T; Minami K; Taniguchi K; Tanaka T; Uehara H; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Ohno Y; Azuma H
BMC Cancer; 2021 Feb; 21(1):201. PubMed ID: 33639880
[TBL] [Abstract][Full Text] [Related]
7. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis.
Kim H; Kim JK; Ye C; Choi JH; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Sci Rep; 2021 Feb; 11(1):2919. PubMed ID: 33536492
[TBL] [Abstract][Full Text] [Related]
8. Impact of Body Composition in Overweight and Obese Patients With Localised Renal Cell Carcinoma.
Darbas T; Forestier G; Leobon S; Pestre J; Jesus P; Lachatre D; Tubiana-Mathieu N; Descazeaud A; Deluche E
In Vivo; 2020; 34(5):2873-2881. PubMed ID: 32871827
[TBL] [Abstract][Full Text] [Related]
9. Obesity: An independent protective factor for localized renal cell carcinoma in a systemic inflammation state.
Liu Z; Wang H; Chen Y; Jin J; Yu W
Int Braz J Urol; 2020; 46(4):585-598. PubMed ID: 32213207
[TBL] [Abstract][Full Text] [Related]
10. The obesity paradox in cancer: clinical insights and perspectives.
Trestini I; Carbognin L; Bonaiuto C; Tortora G; Bria E
Eat Weight Disord; 2018 Apr; 23(2):185-193. PubMed ID: 29492860
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.
Kriegmair MC; Mandel P; Porubsky S; Dürr J; Huck N; Nuhn P; Pfalzgraf D; Michel MS; Wagener N
Horm Cancer; 2017 Apr; 8(2):127-134. PubMed ID: 28247362
[TBL] [Abstract][Full Text] [Related]
12. The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox".
Ito R; Narita S; Huang M; Nara T; Numakura K; Takayama K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
PLoS One; 2017; 12(2):e0171615. PubMed ID: 28178338
[TBL] [Abstract][Full Text] [Related]
13. Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma.
Donin NM; Pantuck A; Klöpfer P; Bevan P; Fall B; Said J; Belldegrun AS; Chamie K
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1326-32. PubMed ID: 27418270
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.
Choi Y; Park B; Jeong BC; Seo SI; Jeon SS; Choi HY; Adami HO; Lee JE; Lee HM
Int J Cancer; 2013 Feb; 132(3):625-34. PubMed ID: 22610826
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
16. Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
Goebell PJ; Müller L; Hübner A; Harich HD; Boller E; Koska M; Jänicke M; Marschner N;
Urol Oncol; 2018 Oct; 36(10):470.e1-470.e9. PubMed ID: 30131294
[TBL] [Abstract][Full Text] [Related]
17. Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials.
Greenlee H; Unger JM; LeBlanc M; Ramsey S; Hershman DL
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):21-29. PubMed ID: 27986655
[TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival.
Gild P; Ehdaie B; Kluth LA
Curr Opin Urol; 2017 Sep; 27(5):409-414. PubMed ID: 28650865
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
